Oral antifungal composition

Details Oral antifungal composition Oral antifungal composition

1997-06-20

1998-12-08

Weddington, Kevin E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514 85, 5142278, 5142362, 514951, A61K 31495, A61K 31675, A61K 3154, A61K 31535

Patent

active

058469710

ABSTRACT:
A pharmaceutical composition comprising:

REFERENCES:
patent: 4791111 (1988-12-01), Heeres et al.
patent: 4853223 (1989-08-01), Graf et al.
patent: 4906478 (1990-03-01), Valentine et al.
patent: 5039676 (1991-08-01), Saksena et al.
patent: 5272137 (1993-12-01), Blase et al.
patent: 5411745 (1995-05-01), Oshlack et al.
patent: 5506248 (1996-04-01), Nikfar et al.
patent: 5580578 (1996-12-01), Oshlack et al.
patent: 5661151 (1997-08-01), Saksena et al.
Surelease Formulation Data for Overcoat Formulation containing Opadry (YS-1-7006), Technical Data by Colorcon, Inc., subsidiary of Berwind Corporation, West Point, PA, (1985), 2 pages.
Peter G. Welling, Pharmacokinetics, Processes and Mathematics, American Chemical Society, Washington, DC, ACS Monograph 185, (1986), p. 57.
J.G. Nairn, Remington's Pharmaceutical Sciences, 18th Edition, (1990), Mack Publishing Co., Chapter 83, p. 1519.
A.A. Nomeir et al., Bioavailability of SCH56592, a new broad spectrum triazole antifungl agent, from various formulations; Abstract of paper presented at 36th ICAAC, New Orleans, Louisiana, (Sep. 15-18, 1996); 1 page.
Pluronic.RTM. and Tetronic.RTM. Surfactants, publication of BASF Corporation, Mount Olive, New Jersey (1989), 29 pages.
Pluronic.RTM.Block Copolymer NF Grade (Poloxamer NF Grades); Technical Bulletin of BASF Corporation, (1995), 2 pages.
W. C. Gunsel and J. L. Kanig, Chapter 11, Tablets, from The Theory and Practice of Industrial Pharmacy, 2nd Edition, Lea&Febiger, Philadelphia, (1976), pp. 321-344.
Van Hostetler and J.Q. Bellard, Chapter 13, Part I. Hard Tablets, from The Theory and Practice of Industrial Pharmacy, 2nd Edition, Lea&Febiger, Philadelphia, 1976,pp.389-404.
A. K. Saksena et al., Concise Asymmetric Routes to 2,2,4-Trisubstituted Tetrahydrofurans via Chiral Titanium Imide Enolates: Key Intermediates Towards Synthesis of Highly Active Azole Antifungals SCH51048 and SCH56592, Tetrahedron Letters, vol. 37, No. 32, (1996), pp. 5657-5660.
D. Loebenberg et al., #46, Formulation studies with SCH56592, a new broad spectrum antifungal triazole, abstract of paper submitted at "Focus on Fungal Infections 6" in New Orleans, Louisiana, Mar. 6-8, 1996, 4 pages.
Sinkula in Annual Reports Medicinal Chemistry, vol. 10, Chapter 31, pp. 306-315 (1975).

Affiliated with

Also associated with

Rating

Oral antifungal composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oral antifungal composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral antifungal composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-177480